Risk factor
Very poor trading liquidity
Profitability factor
Decent dividends
About
Sikarin Public Company Limited, along with its subsidiaries, functions as a healthcare provider managing hospitals throughout Thailand. The company delivers a comprehensive range of medical services and facilities, encompassing specialized care units for diabetes, endocrine disorders, general medicine, orthopedics, emergency and trauma, various surgical procedures, pediatric care, dentistry, aesthetic treatments, women's health, and fertility. Furthermore, it houses dedicated centers for gastroenterology, neurology, stroke, EENT (Ear, Nose, and Throat), and an international medical center. Diagnostic and therapeutic capabilities are robust, featuring a full laboratory department, diagnostic radiology, CT scan and MRI units, multiple operating rooms, a hemodialysis unit, a physical therapy department staffed with rehabilitation specialists, and a catheter laboratory. Patient accommodation includes intensive care units (ICUs), a coronary care unit (CCU), delivery rooms, nurseries, and a variety of inpatient wards such as general, international, obstetrics and gynecology, after heart and thoracic surgery, medical, and pediatric wards. Beyond its core healthcare operations, Sikarin also oversees the management of rental properties and is involved in the sale of food and beverages. The company's hospital portfolio includes Sikarin Hospital in Bangkok, equipped with 355 beds; Rattarin Hospital in Muang, offering 100 beds; and Sikarin Hat-Yai Hospital in Hat Yai, providing 350 beds. Established in 1979, Sikarin Public Company Limited is headquartered in Bangkok, Thailand.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r